about
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerA Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd EditionPrediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry.Identification of a characteristic vascular belt zone in human colorectal cancerAutomatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkersAssociations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Plasma microRNA panel for minimally invasive detection of breast cancerLow penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumTriple-Negative Breast Cancer: Clinical and Histological Correlations.A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerc-myc amplifications in primary breast carcinomas and their local recurrences.19p13.1 is a triple-negative-specific breast cancer susceptibility locus.Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.Common breast cancer susceptibility loci are associated with triple-negative breast cancer.Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical StudiesA meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.Extent of primary breast cancer surgery: standards and individualized conceptsCirculating fibronectin controls tumor growthPrognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.Lean Umbilical Cord - a Case Report.Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012.A program nucleus for encoding and decoding calendar dates.Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma.Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance.Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour.Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin.Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
P50
Q21089802-F2EE9566-A7B7-4495-A270-BEEB195277BFQ28305715-5FA6EA90-9296-410E-A8F9-5D6C49D3F1CFQ33209697-AE370F4A-C88F-4CE3-B13A-22D2BB96B271Q33364892-1A62E101-0FBF-4BF6-B7AE-0659E95C3881Q34098960-751338BF-AB64-43C4-9175-FA48ECDCD406Q35022847-8DDEF797-4560-440C-981C-4F45C54C5D54Q35032320-A71B0BE7-3231-4268-A28C-D2D54B843169Q35119701-585099B1-D101-471D-9534-994727FF86CDQ35576252-2DCCB224-2893-4950-B05E-113C5578C575Q35755874-1277E5EC-B103-4FF4-B2E1-BE49A4BFF4EBQ35769894-A8675258-D108-4475-80E9-03C775398EFFQ35871567-390C956A-BEC7-4F75-9AEB-84A542789B82Q35889217-9C217517-13EC-40FE-BD6C-52D6802F0115Q35891162-F7345A59-B9E8-4B2A-B235-0FA28BDA311BQ35940073-892CB615-7E12-45B3-ACD6-D9D98E072CE6Q36435849-F2B73B40-AF20-4265-8AB8-51CF1755E0CAQ36457859-F068B148-7F8E-4430-A605-B71ACBA0992AQ37061025-902FDA6E-CAD0-40E7-9C9E-173B7B3BFC47Q37350137-3D447DD7-6B64-4C94-8089-DE2FD89D64F1Q37383276-0B53E4E5-CF0F-482F-8C9F-C00822B44AB2Q37385681-1C9020FD-4793-4169-AC96-F721DB5C0AE1Q37441954-85D336B3-C4E9-45BB-8F76-E709C024C32FQ38020788-820D18A3-DB77-4CD6-8320-CC51213410B6Q38519648-573FDE13-B28C-4549-A55F-01B084771E54Q38666974-967A0ECE-D915-4898-BE8C-B6C1DE281AD0Q38913971-9C472A7C-A43C-4751-B0AF-84CF7AC0D2B8Q39081358-57BECA53-AA23-405F-B106-2E363FEF3236Q39162225-79A9BAE9-12BD-403C-9340-C6418FA6CD00Q39238692-90B107A4-31AB-4F03-90AC-EB39B431235FQ39263199-4621B976-DC6A-417D-AE94-A0FB47A444EAQ39465495-02899365-EB26-48E5-B34B-5C9EDC272F6FQ39843631-8EA56316-0891-4E78-BF21-2809095FB7F9Q40386096-ABFB3909-11E3-42EA-9CDC-6E56B3ABD2B0Q40401895-1174C220-E589-4D3C-B11B-E1AF8F1548E3Q41386875-C1111CB4-0E3E-437C-920C-10BEEEDABB5EQ41641041-A180CB25-FE55-4291-9D0E-390EEA417F03Q42171728-330F0FFA-6BF8-446E-9567-6D79C37760B6Q42440577-ED6D5BC3-EB00-428A-AA13-BF36FE3205C3Q42451735-24FA91E9-A7A1-42FD-8E7A-E0BC7EB80866Q42514277-9F1BBF81-2203-4FE6-9C0B-F60811DFF6CF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Sinn
@ast
Peter Sinn
@en
Peter Sinn
@es
Peter Sinn
@nl
Peter Sinn
@sl
type
label
Peter Sinn
@ast
Peter Sinn
@en
Peter Sinn
@es
Peter Sinn
@nl
Peter Sinn
@sl
altLabel
Hans-Peter Sinn
@en
Peter Sinn
@en
prefLabel
Peter Sinn
@ast
Peter Sinn
@en
Peter Sinn
@es
Peter Sinn
@nl
Peter Sinn
@sl
P214
P1053
C-5661-2008
P106
P108
P1153
6602129438
P2038
Peter_Sinn2
P21
P214
P31
P3829
P496
0000-0003-2836-6699
P735
P7859
viaf-313417353